Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

H. Hanna, Nasser; H. Johnson, David; Temin, Sarah; Baker, Sherman; R. Brahmer, Julie; M. Ellis, Peter; Giaccone, Giuseppe; J. Hesketh, Paul; Jaiyesimi, Ishmael; B. Leighl, Natasha; J. Riely, Gregory; H. Schiller, Joan; J. Schneider, Bryan; J. Smith, Thomas; Tashbar, Joan; A. Biermann, William; A. Masters, Gregory

doi:10.1200/jco.2017.74.6065

Public

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Published in Journal of Clinical Oncology • Aug 14, 2017

Authors:

Nasser H. Hanna

David H. Johnson

Sarah Temin

Abstract

Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC). Methods The ASCO NSCLC Expert Panel made recommendations based on a systematic review of randomized controlled trials from February 2014 ...

Subject

Medicine

Atezolizumab

Nivolumab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!